Detalhe da pesquisa
1.
Targeting regulator of G protein signaling 1 in tumor-specific T cells enhances their trafficking to breast cancer.
Nat Immunol
; 22(7): 865-879, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-34140678
2.
Multiclonal Invasion in Breast Tumors Identified by Topographic Single Cell Sequencing.
Cell
; 172(1-2): 205-217.e12, 2018 01 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-29307488
3.
Comprehensive Molecular Portraits of Invasive Lobular Breast Cancer.
Cell
; 163(2): 506-19, 2015 Oct 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-26451490
4.
Peripheral blood TCR clonotype diversity as an age-associated marker of breast cancer progression.
Proc Natl Acad Sci U S A
; 120(49): e2316763120, 2023 Dec 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-38011567
5.
E-cadherin is required for metastasis in multiple models of breast cancer.
Nature
; 573(7774): 439-444, 2019 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-31485072
6.
Circulating levels of biomarkers and risk of ductal carcinoma in situ of the breast in the UK Biobank study.
Int J Cancer
; 154(7): 1191-1203, 2024 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38013398
7.
Adherence to hormonal therapy after surgery among older women with ductal carcinoma in situ: Implications for breast cancer-related adverse health events.
Cancer
; 130(1): 107-116, 2024 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37751195
8.
Nonclinical factors associated with the treatment of older women with newly diagnosed low-grade ductal carcinoma in situ.
Cancer
; 130(7): 1041-1051, 2024 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37987170
9.
Tumor microenvironment and immune system preservation in early-stage breast cancer: routes for early recurrence after mastectomy and treatment for lobular and ductal forms of disease.
BMC Immunol
; 25(1): 9, 2024 01 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-38273260
10.
Secretory breast carcinoma: clinicopathological features and prognosis of 52 patients.
Breast Cancer Res Treat
; 203(3): 543-551, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-37897648
11.
Potential role of Fbxo22 in resistance to endocrine therapy in breast cancer with invasive lobular carcinoma.
Breast Cancer Res Treat
; 204(3): 453-463, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38180699
12.
Multi-omic profiling of simultaneous ductal carcinoma in situ and invasive breast cancer.
Breast Cancer Res Treat
; 205(3): 451-464, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38523186
13.
Breast surgery after neoadjuvant chemotherapy in patients with lobular carcinoma: surgical and oncologic outcome.
Breast Cancer Res Treat
; 204(3): 497-507, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38189904
14.
Nonlobular Invasive Breast Carcinomas with Biallelic Pathogenic CDH1 Somatic Alterations: A Histologic, Immunophenotypic, and Genomic Characterization.
Mod Pathol
; 37(2): 100375, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-37925055
15.
Computer Vision Identifies Recurrent and Nonrecurrent Ductal Carcinoma in Situ Lesions with Special Emphasis on African-American Women.
Am J Pathol
; 193(9): 1195-1207, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37355038
16.
Tumor Characteristics of Bilateral Breast Cancer Compared with Unilateral Breast Cancer.
Ann Surg Oncol
; 31(2): 947-956, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-37906382
17.
Nationwide Analysis of Locoregional Management for Ductal Carcinoma In Situ in Males: An NCDB Analysis of the Surgical Approach to DCIS in Males.
Ann Surg Oncol
; 31(3): 1599-1607, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-37978114
18.
Lobular-Like Features and Outcomes of Mixed Invasive Ductolobular Breast Cancer (MIDLC): Insights from 54,403 Stage I-III MIDLC Patients.
Ann Surg Oncol
; 31(2): 936-946, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-37872454
19.
Clinicopathological Predictors of Positive Resection Margins in Breast-Conserving Surgery.
Ann Surg Oncol
; 31(6): 3939-3947, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38520579
20.
Determination of Factors Associated with Upstage in Atypical Ductal Hyperplasia to Identify Low-Risk Patients Where Active Surveillance May be an Alternative.
Ann Surg Oncol
; 31(5): 3177-3185, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38386195